REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 75 filers reported holding REPARE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.06 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,456 | +14.2% | 700,000 | 0.0% | 0.36% | +57.8% |
Q2 2023 | $7,406 | +7.5% | 700,000 | 0.0% | 0.23% | -43.8% |
Q1 2023 | $6,888 | -33.1% | 700,000 | 0.0% | 0.41% | -28.9% |
Q4 2022 | $10,297 | -99.9% | 700,000 | 0.0% | 0.58% | +58.8% |
Q3 2022 | $8,491,000 | -13.3% | 700,000 | 0.0% | 0.36% | -30.8% |
Q2 2022 | $9,793,000 | -1.8% | 700,000 | 0.0% | 0.52% | +25.4% |
Q1 2022 | $9,968,000 | -32.5% | 700,000 | 0.0% | 0.42% | +4.0% |
Q4 2021 | $14,763,000 | +2.3% | 700,000 | +27.3% | 0.40% | +24.1% |
Q3 2021 | $14,432,000 | -15.8% | 550,000 | 0.0% | 0.32% | -7.2% |
Q2 2021 | $17,149,000 | +1.6% | 550,000 | 0.0% | 0.35% | +16.8% |
Q1 2021 | $16,880,000 | -13.7% | 550,000 | -3.5% | 0.30% | -29.0% |
Q4 2020 | $19,551,000 | +11.5% | 570,000 | 0.0% | 0.42% | -1.4% |
Q3 2020 | $17,539,000 | -5.8% | 570,000 | -5.0% | 0.43% | -18.2% |
Q2 2020 | $18,612,000 | – | 600,000 | – | 0.52% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,646,657 | $31,971,617 | 17.00% |
MPM ASSET MANAGEMENT LLC | 2,242,636 | $27,091,043 | 14.51% |
CHI Advisors LLC | 2,966,674 | $35,837,422 | 14.20% |
MPM BioImpact LLC | 1,639,849 | $19,809,376 | 5.29% |
BVF INC/IL | 8,291,988 | $100,167,215 | 2.70% |
Deep Track Capital, LP | 3,067,731 | $37,058,190 | 1.43% |
Redmile Group, LLC | 2,404,695 | $29,048,716 | 1.38% |
HighVista Strategies LLC | 165,173 | $1,995,290 | 0.92% |
Orbimed Advisors | 3,322,488 | $40,135,655 | 0.85% |
Logos Global Management LP | 500,000 | $6,040,000 | 0.81% |